These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2777445)

  • 1. Plasminogen activators and antiplasmin activity in atopic dermatitis.
    Lotti T; Battini ML; Brunetti L; Fabbri P; Panconesi E
    Int J Dermatol; 1989 Sep; 28(7):457-9. PubMed ID: 2777445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of coronary artery disease and basal fibrinolysis.
    Small M; Lowe GD; Beattie JM; Hutton I; Lorimer AR; Forbes CD
    Haemostasis; 1987; 17(5):305-11. PubMed ID: 2444504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
    Collen D; Van Hoef B; Schlott B; Hartmann M; Gührs KH; Lijnen HR
    Eur J Biochem; 1993 Aug; 216(1):307-14. PubMed ID: 7689966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous and plasma fibrinolytic activity in systemic sclerosis. Evidence of normal plasminogen activation.
    Matucci-Cerinic M; Lotti T; Lombardi A; Pignone A; Iannone F; Beneforti E; Cinotti S; Morfini M; Caignoni M
    Int J Dermatol; 1990 Nov; 29(9):644-8. PubMed ID: 2125582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Participation of the kidney in changes in the fibrinolytic system during electroshock].
    Andreenko GV; Podorol'skaia LV
    Vopr Med Khim; 1984; 30(4):39-42. PubMed ID: 6542276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressed fibrinolysis in patients with acute leukaemia.
    Guarini A; Mussoni L; Gugliotta L; Chetti L; Niewiarowski T; Catani L; Macchi S; Donati MB; Tura S
    Br J Haematol; 1987 Jul; 66(3):327-30. PubMed ID: 2441734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired fibrinolysis and protein C increase after cadaver kidney transplantation.
    Seitz R; Michalik R; Karges HE; Lange H; Egbring R
    Thromb Res; 1986 May; 42(3):277-88. PubMed ID: 2424120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in fibrinolytic activity during the course of a single hemodialysis session.
    Kurz H; Lerner RG; Weseley S; Nelson JC
    Clin Nephrol; 1985 Jul; 24(1):1-4. PubMed ID: 4040447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia.
    Avvisati G; ten Cate JW; Sturk A; Lamping R; Petti MG; Mandelli F
    Br J Haematol; 1988 Sep; 70(1):43-8. PubMed ID: 2460126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
    Singh S; Houng A; Reed GL
    Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura.
    Glas-Greenwalt P; Hall JM; Panke TW; Kant KS; Allen CM; Pollak VE
    J Lab Clin Med; 1986 Nov; 108(5):415-22. PubMed ID: 2430036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).
    Du XH; Glas-Greenwalt P; Kant KS; Allen CM; Hayes S; Pollak VE
    Clin Nephrol; 1985 Oct; 24(4):186-91. PubMed ID: 3933871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
    Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH
    Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma fibrinolytic activity in patients undergoing major abdominal surgery.
    Mellbring G; Dahlgren S; Wiman B
    Acta Chir Scand; 1985; 151(2):109-14. PubMed ID: 3873768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.